Webinar: Controlled Release for Nutraceuticals
![Webinar Controlled Release for Nutraceuticals](https://www.pharmaexcipients.com/wp-content/uploads/2024/08/Webinar-Controlled-Release-for-Nutraceuticals.jpg)
We invite you to our next webinar:
“Controlled Release for Nutraceuticals”
During this webinar we will cover the key topics related to controlled release for nutraceuticals.
We will address:
- New trends in enteric coating excipients by Marek Lachmann from BIOGRUND
- Mechanistic study of cellulose ether to control the release of the API by David Nakhia from Shin-Etsu
- Innovative technique for the granulation and coating processes, controlled release via Hot Melt fluidized bed by Dr. Lars Reinders from ROMACO
Date & Time & Timezone: Sep 10, 2024 05:00 PM CET
Get more information & register here for free:
Speaker:
Marek Lachmann
Head of Research, BIOGRUND GmbH
Marek is a skilled pharmaceutical engineer and technician. He held several positions as a Senior Researcher, Innovation and Application Development Manager and Technical Manager in international pharmaceutical companies. The passionate researcher works at BIOGRUND GmbH as Head of Research where he is responsible for the development and optimisation of modern ready-to-use tableting and film coating premixes.
David Nakhla, Ph.D
Laboratory manager, Formulation scientist, SE Tylose USA, Inc.
David Nakhla is a pharmacist with a master’s degree in pharmaceutical analytical chemistry and a PhD degree in pharmaceutics from the University of Iowa. David currently holds the position of the lab manager and formulation scientist at SE Tylose USA pharmaceutical application laboratory in New Jersey.
Dr. Lars Reinders
Head of Laboratory, Romaco Innojet GmbH
Dr. Lars Reinders has been working as a head of laboratory at Romaco Innojet GmbH since 2023. Together with his team, he processes pharmaceutical and nutraceutical raw materials using granulation, coating and hot melt processes in fluidized bed reactors. His field of work includes the establishment and optimization of existing formulations, their reformulation or the creation of new formulations. Before joining Romaco Innojet GmbH, Dr. Lars Reinders worked intensively on the topics of occupational safety in the aseptic production of personalized medicines and the analysis of pharmaceuticals. As part of his dissertation, he focused on cytostatics and monoclonal antibodies.
For more information & registration here: